MedTrace Logo

Effect of SVV-guided Fluid Therapy on Outcomes After Major Abdominal Surgery

NCT03940144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-03-09

No results posted yet for this study

Summary

The investigators conduct this randomized assessor-blinded controlled trial to evaluate the effect of SVV-guided fluid therapy on postoperative morbidity and mortality in comparison with conventional fluid therapy after major abdominal surgery. Half of participants will receive GDFT perioperatively, and the others will receive conventional fluid therapy

Conditions

  • Goal-directed Fluid Therapy

Interventions

DEVICE

the enhanced flow-based hemodynamic parameters of the FloTrac/Vigileo device

Stroke volume variation (SVV)-guided fluid therapy

Sponsors & Collaborators

  • Beijing Tongren Hospital

    lead OTHER

Principal Investigators

  • Yanxia Sun, M.D. · Beijing Tong Ren Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2021-01-31
Completion
2021-02-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940144 on ClinicalTrials.gov